CN1814215A - Medicine for treating gout and gout arthritis - Google Patents
Medicine for treating gout and gout arthritis Download PDFInfo
- Publication number
- CN1814215A CN1814215A CN 200510022230 CN200510022230A CN1814215A CN 1814215 A CN1814215 A CN 1814215A CN 200510022230 CN200510022230 CN 200510022230 CN 200510022230 A CN200510022230 A CN 200510022230A CN 1814215 A CN1814215 A CN 1814215A
- Authority
- CN
- China
- Prior art keywords
- parts
- medicine
- water
- filtrate
- raw material
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 201000005569 Gout Diseases 0.000 title claims abstract description 19
- 239000003814 drug Substances 0.000 title claims description 56
- 229940079593 drug Drugs 0.000 title claims description 13
- 206010003246 arthritis Diseases 0.000 title abstract description 3
- 239000000706 filtrate Substances 0.000 claims abstract description 23
- 239000002994 raw material Substances 0.000 claims abstract description 20
- 238000002360 preparation method Methods 0.000 claims abstract description 19
- 239000007788 liquid Substances 0.000 claims abstract description 13
- 238000000034 method Methods 0.000 claims abstract description 10
- 239000000203 mixture Substances 0.000 claims abstract description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 41
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 35
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 27
- 210000000582 semen Anatomy 0.000 claims description 20
- 125000003118 aryl group Chemical group 0.000 claims description 16
- 241000255789 Bombyx mori Species 0.000 claims description 10
- 239000012567 medical material Substances 0.000 claims description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 7
- 238000004821 distillation Methods 0.000 claims description 7
- 230000008030 elimination Effects 0.000 claims description 7
- 238000003379 elimination reaction Methods 0.000 claims description 7
- 238000004321 preservation Methods 0.000 claims description 7
- 238000004064 recycling Methods 0.000 claims description 7
- 206010018634 Gouty Arthritis Diseases 0.000 claims description 6
- 239000012141 concentrate Substances 0.000 claims description 6
- 235000008504 concentrate Nutrition 0.000 claims description 6
- 241000202755 Areca Species 0.000 claims description 5
- 230000006837 decompression Effects 0.000 claims description 5
- 239000008187 granular material Substances 0.000 claims description 5
- 235000004347 Perilla Nutrition 0.000 claims description 4
- 241000229722 Perilla <angiosperm> Species 0.000 claims description 4
- 241001078983 Tetradium ruticarpum Species 0.000 claims description 4
- 239000002671 adjuvant Substances 0.000 claims description 4
- 238000000605 extraction Methods 0.000 claims description 4
- 239000006187 pill Substances 0.000 claims description 4
- 239000007787 solid Substances 0.000 claims description 4
- 230000001154 acute effect Effects 0.000 claims description 3
- 238000009472 formulation Methods 0.000 claims description 3
- 239000000843 powder Substances 0.000 claims description 3
- 239000002775 capsule Substances 0.000 claims description 2
- 239000006196 drop Substances 0.000 claims description 2
- 239000000839 emulsion Substances 0.000 claims description 2
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 claims description 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 2
- 229920000053 polysorbate 80 Polymers 0.000 claims description 2
- 229940075582 sorbic acid Drugs 0.000 claims description 2
- 235000010199 sorbic acid Nutrition 0.000 claims description 2
- 239000004334 sorbic acid Substances 0.000 claims description 2
- 239000006188 syrup Substances 0.000 claims description 2
- 235000020357 syrup Nutrition 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 239000000243 solution Substances 0.000 claims 3
- 230000000694 effects Effects 0.000 abstract description 9
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 abstract description 5
- 208000002193 Pain Diseases 0.000 abstract description 5
- 230000008961 swelling Effects 0.000 abstract description 3
- 206010014025 Ear swelling Diseases 0.000 abstract description 2
- 208000026816 acute arthritis Diseases 0.000 abstract description 2
- 239000003292 glue Substances 0.000 abstract description 2
- 238000012360 testing method Methods 0.000 abstract description 2
- 210000002683 foot Anatomy 0.000 abstract 2
- 239000003390 Chinese drug Substances 0.000 abstract 1
- 241000206575 Chondrus crispus Species 0.000 abstract 1
- 241000675108 Citrus tangerina Species 0.000 abstract 1
- 244000077995 Coix lacryma jobi Species 0.000 abstract 1
- 241000893536 Epimedium Species 0.000 abstract 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 235000018905 epimedium Nutrition 0.000 abstract 1
- 238000001914 filtration Methods 0.000 abstract 1
- 238000005469 granulation Methods 0.000 abstract 1
- 230000003179 granulation Effects 0.000 abstract 1
- 229910052708 sodium Inorganic materials 0.000 abstract 1
- 239000011734 sodium Substances 0.000 abstract 1
- 210000003371 toe Anatomy 0.000 abstract 1
- 230000006870 function Effects 0.000 description 12
- 210000004369 blood Anatomy 0.000 description 11
- 239000008280 blood Substances 0.000 description 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 201000010099 disease Diseases 0.000 description 5
- 244000052769 pathogen Species 0.000 description 5
- 230000001717 pathogenic effect Effects 0.000 description 5
- 206010062717 Increased upper airway secretion Diseases 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 208000026435 phlegm Diseases 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 239000003172 expectorant agent Substances 0.000 description 3
- 230000003419 expectorant effect Effects 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 231100000862 numbness Toxicity 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 208000006820 Arthralgia Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000002481 ethanol extraction Methods 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 229940126701 oral medication Drugs 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 208000037920 primary disease Diseases 0.000 description 2
- 230000002040 relaxant effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 210000002435 tendon Anatomy 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 239000003643 water by type Substances 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010023232 Joint swelling Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 208000035977 Rare disease Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000000146 antalgic effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000009172 bursting Effects 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000006184 cosolvent Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 210000001503 joint Anatomy 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- NAFSTSRULRIERK-UHFFFAOYSA-M monosodium urate Chemical compound [Na+].N1C([O-])=NC(=O)C2=C1NC(=O)N2 NAFSTSRULRIERK-UHFFFAOYSA-M 0.000 description 1
- 208000038009 orphan disease Diseases 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 230000004144 purine metabolism Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 210000001113 umbilicus Anatomy 0.000 description 1
- 230000009278 visceral effect Effects 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100222309A CN100443112C (en) | 2005-12-06 | 2005-12-06 | Medicine for treating gout and gout arthritis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100222309A CN100443112C (en) | 2005-12-06 | 2005-12-06 | Medicine for treating gout and gout arthritis |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1814215A true CN1814215A (en) | 2006-08-09 |
CN100443112C CN100443112C (en) | 2008-12-17 |
Family
ID=36906647
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2005100222309A Active CN100443112C (en) | 2005-12-06 | 2005-12-06 | Medicine for treating gout and gout arthritis |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100443112C (en) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101204545B (en) * | 2007-12-12 | 2010-12-15 | 王芳 | Medicine for shoulder periarthritis |
CN102657737A (en) * | 2012-03-21 | 2012-09-12 | 潘�清 | Medicament for treating acute gouty arthritis |
CN102755598A (en) * | 2012-08-02 | 2012-10-31 | 侯可强 | Medicine for treating acute gouty arthritis and preparation method thereof |
CN103611085A (en) * | 2013-12-05 | 2014-03-05 | 侯青兰 | Medicament for treating gouty arthritis and preparation method thereof |
CN103735630A (en) * | 2013-12-25 | 2014-04-23 | 柳州市中医院 | Traditional Chinese medicine for treating gout |
CN104491253A (en) * | 2015-01-26 | 2015-04-08 | 于贵庆 | Traditional Chinese medicine composition used for treating acute gouty arthritis |
CN105169096A (en) * | 2014-08-06 | 2015-12-23 | 成都中医药大学附属医院 | Medicine composition for treating gout or/and hyperuricemia |
CN105362745A (en) * | 2015-11-14 | 2016-03-02 | 刘淑芳 | Traditional Chinese medicinal composition for treating front foot swelling after hallux valgus operation and nursing method |
CN113398232A (en) * | 2021-05-31 | 2021-09-17 | 四川升和药业股份有限公司 | Preparation method of pharmaceutical composition for treating gout and gouty arthritis |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1106674A (en) * | 1994-10-13 | 1995-08-16 | 汪志伟 | Traditional Chinese medicine for curing paralysis |
-
2005
- 2005-12-06 CN CNB2005100222309A patent/CN100443112C/en active Active
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101204545B (en) * | 2007-12-12 | 2010-12-15 | 王芳 | Medicine for shoulder periarthritis |
CN102657737A (en) * | 2012-03-21 | 2012-09-12 | 潘�清 | Medicament for treating acute gouty arthritis |
CN102755598A (en) * | 2012-08-02 | 2012-10-31 | 侯可强 | Medicine for treating acute gouty arthritis and preparation method thereof |
CN103611085A (en) * | 2013-12-05 | 2014-03-05 | 侯青兰 | Medicament for treating gouty arthritis and preparation method thereof |
CN103611085B (en) * | 2013-12-05 | 2015-07-01 | 侯青兰 | Medicament for treating gouty arthritis and preparation method thereof |
CN103735630A (en) * | 2013-12-25 | 2014-04-23 | 柳州市中医院 | Traditional Chinese medicine for treating gout |
CN103735630B (en) * | 2013-12-25 | 2016-03-30 | 柳州市中医院 | A kind of Chinese medicine for the treatment of gout |
CN105169096A (en) * | 2014-08-06 | 2015-12-23 | 成都中医药大学附属医院 | Medicine composition for treating gout or/and hyperuricemia |
CN105169096B (en) * | 2014-08-06 | 2018-11-13 | 成都中医药大学附属医院 | A kind of pharmaceutical composition for treating gout or/and hyperuricemia |
CN104491253A (en) * | 2015-01-26 | 2015-04-08 | 于贵庆 | Traditional Chinese medicine composition used for treating acute gouty arthritis |
CN105362745A (en) * | 2015-11-14 | 2016-03-02 | 刘淑芳 | Traditional Chinese medicinal composition for treating front foot swelling after hallux valgus operation and nursing method |
CN113398232A (en) * | 2021-05-31 | 2021-09-17 | 四川升和药业股份有限公司 | Preparation method of pharmaceutical composition for treating gout and gouty arthritis |
Also Published As
Publication number | Publication date |
---|---|
CN100443112C (en) | 2008-12-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100443112C (en) | Medicine for treating gout and gout arthritis | |
CN101391077B (en) | Preparation method of traditional Chinese medicine for treating chronic pelvic inflammatory disease | |
CN102370949A (en) | Chinese medicinal compound preparation for treating cholecystitis and preparation method thereof | |
CN1931245B (en) | Medicine for treating gouty arthritis and its preparation process and application | |
CN101041050A (en) | Chinese traditional medicine compound took orally for treating chronic gastritis | |
CN104547775A (en) | Traditional Chinese medicine for treating syndrome of dampness-heat in middle jiao | |
CN106266463B (en) | Traditional Chinese medicine composition for treating hyperuricemia and application thereof | |
CN103656499B (en) | A kind of Traditional Chinese drug mixture treating cystic polyp and preparation method thereof | |
CN100360161C (en) | Chinese medicine for treating diabets and nephritis | |
CN101590166B (en) | Traditional Chinese medicine combination for treating gout and preparation method thereof | |
CN1284593C (en) | Medicine for treating anaphylactoid purpura | |
CN103386101B (en) | Traditional Chinese medicine preparation for nonspecific cystitis treatment and preparation method thereof | |
CN101357187A (en) | Medicine for treating the prostatitis | |
CN101732657A (en) | Medicine composition | |
CN106728388B (en) | Traditional Chinese medicine composition for treating hypertension and application thereof | |
CN104107352A (en) | Chinese herbal medicine for blood pressure reducing, and administration method thereof | |
CN103638447A (en) | Traditional Chinese medicine composition used for treating cholecystitis, and applications thereof | |
CN103100063A (en) | Traditional Chinese medicine for treating damp-heat type gallstone | |
CN102233004B (en) | Drug for treating liver diseases | |
CN101879227B (en) | Chinese medicinal composition for treating protrusion of lumbar intervertebral disci and preparation method thereof | |
CN102228661B (en) | Chinese medicinal cholecystitis treatment mixture for treating chronic cholecystitis | |
CN106581468A (en) | Preparation method of traditional Chinese medicine capable of treating gastric ulcer | |
CN1194722C (en) | Shugan Zhitong soft extract for treating hepatitis | |
CN106237014A (en) | A kind of Chinese medicine composition treating chronic nephritis | |
CN105832934A (en) | Traditional Chinese medicine for treating hypertension |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: ZHONGHUI PHARMACY CO., LTD., CHENGDU Free format text: FORMER OWNER: YATAI PHARMACEUTICAL INDUSTRY CO., LTD., SICHUAN Effective date: 20070518 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20070518 Address after: 610036 No. 30 Shu West Road, Sichuan, Chengdu Applicant after: Zhonghui Pharmaceutical Co., Ltd., Chengdu City Address before: 611130, Xiangyang Road 298, Chengdu science and Technology Industrial Development Zone, Chengdu Strait, Wenjiang District, Sichuan, China Applicant before: Yatai Pharmaceutical Industry Co., Ltd., Sichuan |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: SICHUAN SUNNYHOPE PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: ZHONGHUI PHARMACEUTICAL CO., LTD., CHENGDU CITY Effective date: 20120203 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 610036 CHENGDU, SICHUAN PROVINCE TO: 610041 CHENGDU, SICHUAN PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20120203 Address after: No. 3 high tech Zone Gaopeng road in Chengdu city of Sichuan Province in 610041 Patentee after: Sichuan Sunnyhope Pharmaceutical Co., Ltd. Address before: 610036 No. 30 Shu West Road, Sichuan, Chengdu Patentee before: Zhonghui Pharmaceutical Co., Ltd., Chengdu City |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Medicine for treating gout and gout arthritis Effective date of registration: 20141120 Granted publication date: 20081217 Pledgee: China Huarong Asset Management Limited by Share Ltd Sichuan branch Pledgor: Sichuan Sunnyhope Pharmaceutical Co., Ltd. Registration number: 2014510000035 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20180209 Granted publication date: 20081217 Pledgee: China Huarong Asset Management Limited by Share Ltd Sichuan branch Pledgor: Sichuan Sunnyhope Pharmaceutical Co., Ltd. Registration number: 2014510000035 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |